These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 660471)

  • 1. Simultaneous determination of procainamide and N-acetylprocainamide in plasma by high-performance liquid chromatography.
    Butterfield AG; Cooper JK; Midha KK
    J Pharm Sci; 1978 Jun; 67(6):839-42. PubMed ID: 660471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and micro high-pressure liquid chromatographic method for simultaneous determination of procainamide and N-acetylprocainamide in plasma.
    Gadalla MA; Peng GW; Chiou WL
    J Pharm Sci; 1978 Jun; 67(6):869-71. PubMed ID: 660479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of procainamide and N-acetylprocainamide in biological fluids by high-pressure liquid chromatography.
    Lai CM; Kamath BL; Look ZM; Yacobi A
    J Pharm Sci; 1980 Aug; 69(8):982-4. PubMed ID: 6157019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of plasma procainamide and N-acetylprocainamide concentration by high-pressure liquid chromatography.
    Dutcher JS; Strong JM
    Clin Chem; 1977 Jul; 23(7):1318-20. PubMed ID: 872378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved high-performance liquid chromatographic assay for the determination of procainamide and its N-acetylated metabolite in plasma: application to a single-dose pharmacokinetic study.
    Lessard E; Fortin A; Coquet A; Bélanger PM; Hamelin BA; Turgeon J
    J Chromatogr Sci; 1998 Jan; 36(1):49-54. PubMed ID: 9443381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High performance liquid chromatography of procainamide and N-acetylprocainamide in human blood plasma.
    Raphanaud D; Borensztejn M; Dupeyron JP; Guyon F
    Ther Drug Monit; 1986; 8(3):365-7. PubMed ID: 2428144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantification of procainamide and N-acetylprocainamide with high-performance liquid chromatography.
    Carr K; Woosley RL; Oates JA
    J Chromatogr; 1976 Dec; 129():363-8. PubMed ID: 1002795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved liquid chromatographic determination of procainamide and N-acetylprocainamide in serum.
    Patel CP
    Ther Drug Monit; 1983 Jun; 5(2):235-8. PubMed ID: 6192559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatographic analysis of mexiletine in serum, with alternate application to tocainide, procainamide, and N-acetylprocainamide.
    vasBinder E; Annesley T
    Biomed Chromatogr; 1991 Jan; 5(1):19-22. PubMed ID: 1709575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longer plasma half-life for procainamide utilizing a very sensitive high performance liquid chromatography assay.
    Jamali F; Alballa RS; Mehvar R; Lemko CH
    Ther Drug Monit; 1988; 10(1):91-6. PubMed ID: 2453956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme immunoassay, liquid chromatography, and spectrofluorometry compared for the determination of procainamide and N-acetylprocainamide in serum.
    Pape BE
    J Anal Toxicol; 1982; 6(1):44-8. PubMed ID: 6176781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroimmunoassays for procainamide and N-acetylprocainamide compared with a liquid-chromatographic method.
    MacKichan JJ; Coyle JD; Shields BJ; Boudoulas H; Lima JJ
    Clin Chem; 1984 May; 30(5):768-73. PubMed ID: 6201304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precaution in use of high-pressure liquid chromatographic simultaneous plasma procainamide and N-acetylprocainamide determination.
    Nation RL; Lee MG; Huang SM; Chiou WL
    J Pharm Sci; 1979 Apr; 68(4):532-4. PubMed ID: 438989
    [No Abstract]   [Full Text] [Related]  

  • 14. A high performance liquid chromatographic assay for tocainide with alternate application for the determination of lidocaine, procainamide, and N-acetylprocainamide.
    Annesley T; Matz K; Davenport R; Giacherio D
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):173-81. PubMed ID: 2421377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High performance liquid chromatographic analysis of the antiarrhythmic drugs procainamide, disopyramide, quinidine, propranolol and metabolites from serum extracts.
    Wesley JF; Lasky FD
    Clin Biochem; 1981 Jun; 14(3):113-8. PubMed ID: 6170476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversed-phase liquid chromatography method for measurement of procainamide and three metabolites in serum and urine: percent of dose excreted as deethyl metabolites.
    Coyle JD; MacKichan JJ; Boudoulas H; Lima JJ
    J Pharm Sci; 1987 May; 76(5):402-5. PubMed ID: 2443639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of procainamide and N-acetylprocainamide in serum by high-performance liquid chromatography.
    Shukur LR; Powers JL; Marques RA; Winter ME; Sadée W
    Clin Chem; 1977; 23(4):636-8. PubMed ID: 844158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of the EMIT procainamide and N-acetylprocainamide assay.
    Walberg CB; Wan SH
    Ther Drug Monit; 1979; 1(1):47-56. PubMed ID: 95422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of phenylbutazone and oxyphenbutazone in plasma by high-speed liquid chromatography.
    Pound NJ; Sears RW
    J Pharm Sci; 1975 Feb; 64(2):284-7. PubMed ID: 1127584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative thin-layer chromatographic method for the determination of procainamide and its major metabolite in plasma.
    Wesley-Hadzija B; Mattocks AM
    J Chromatogr; 1977 May; 143(3):307-13. PubMed ID: 863987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.